Advanced Non-Central Nervous System (CNS) Malignancies

1 clinical trials · Condition

Record	Firm	Date
A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies (NCT02244112)	Amgen	2014-08-01

Every clearance here is in the API, with alerts when new ones post.